FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Arrand

Research Profile

Living Beings

Concepts & Ideas

Molecular Sequence Data

Chemicals & Drugs

Disorders

Genes & Molecular Sequences

Anatomy

Cell Line

Phenomena

Blotting, Western

Co-author Network

Publications

TOP 3
Alexandra Schrader; Rainer Spang; Lorenz Trümper; John R Arrand; Stefan Bentink; Michael Hummel; Martin Hafner; Michael Kuo; Dido Lenze; Paul G Murray; Martina Vockerodt
High Myc activity is an independent negative prognostic factor for diffuse large B cell lymphomas.
Chunfang Hu; Irène Joab; Stephanie L Maloney; Paul G Murray; John M Nicholls; Jian-Yong Shao; Sim K Sihota; Wenbin Wei; Ciaran B Woodman; Yunhong Yao; Lawrence S Young; Andrew I Bell; Xiaoyi Chen; Christopher W Dawson; K Dalia Derkaoui; Aicha Amari; John R Arrand
A global view of the oncogenic landscape in nasopharyngeal carcinoma: an integrated analysis at the genetic and expression levels.
Thomas J Owen; JD O'Neil; Christopher W Dawson; Chunfang Hu; Xiaoyi Chen; Yunhong Yao; Victoria H J Wood; Louise E Mitchell; Robert J White; Lawrence S Young; John R Arrand
Epstein-Barr virus-encoded EBNA1 enhances RNA polymerase III-dependent EBER expression through induction of EBER-associated cellular transcription factors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Arrand (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Alexandra Schrader; Rainer Spang; Lorenz Trümper; John R Arrand; Stefan Bentink; Michael Hummel; Martin Hafner; Michael Kuo; Dido Lenze; Paul G Murray; Martina Vockerodt
High Myc activity is an independent negative prognostic factor for diffuse large B cell lymphomas.
International journal of cancer. Journal international du cancer 2012;131(4):E348-61.
2012: Chunfang Hu; Irène Joab; Stephanie L Maloney; Paul G Murray; John M Nicholls; Jian-Yong Shao; Sim K Sihota; Wenbin Wei; Ciaran B Woodman; Yunhong Yao; Lawrence S Young; Andrew I Bell; Xiaoyi Chen; Christopher W Dawson; K Dalia Derkaoui; Aicha Amari; John R Arrand
A global view of the oncogenic landscape in nasopharyngeal carcinoma: an integrated analysis at the genetic and expression levels.
PloS one 2012;7(7):e41055.
2010: Thomas J Owen; JD O'Neil; Christopher W Dawson; Chunfang Hu; Xiaoyi Chen; Yunhong Yao; Victoria H J Wood; Louise E Mitchell; Robert J White; Lawrence S Young; John R Arrand
Epstein-Barr virus-encoded EBNA1 enhances RNA polymerase III-dependent EBER expression through induction of EBER-associated cellular transcription factors.
Molecular cancer 2010;9():241.
2010: Robert Valentine; Christopher W Dawson; Chunfang Hu; Khilan M Shah; Owen Tom; Kathryn L Date; Sonia P Maia; Jianyong Shao; John R Arrand; Lawrence S Young; JD O'Neil
Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-kappaB pathway in carcinoma cells by inhibiting IKK phosphorylation.
Molecular cancer 2010;9():1.
2008: JD O'Neil; Owen Tom; Victoria H J Wood; Kathryn L Date; Robert Valentine; Marilyn B Chukwuma; John R Arrand; Christopher W Dawson; Lawrence S Young
Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro.
The Journal of general virology 2008;89(Pt 11):2833-42.
2008: Mhairi A Morris; Christopher W Dawson; wenbin Wei; JD O'Neil; Suzanne E Stewart; Junying Jia; Andrew I Bell; Lawrence S Young; John R Arrand
Epstein-Barr virus-encoded LMP1 induces a hyperproliferative and inflammatory gene expression programme in cultured keratinocytes.
The Journal of general virology 2008;89(Pt 11):2806-20.
2007: Ross Stewart; wenbin Wei; Anita Challa; Richard J Armitage; John R Arrand; Martin Rowe; Lawrence S Young; Aristides G Eliopoulos; John Gordon
CD154 tone sets the signaling pathways and transcriptome generated in model CD40-pluricompetent L3055 Burkitt's lymphoma cells.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(5):2705-12.
2006: Zoë A Felton-Edkins; Alexander Kondrashov; Dimitra Karali; Jennifer A Fairley; Christopher W Dawson; John R Arrand; Lawrence S Young; Robert J White
Epstein-Barr virus induces cellular transcription factors to allow active expression of EBER genes by RNA polymerase III.
The Journal of biological chemistry 2006;281(45):33871-80.
2004: Shahram Salek-Ardakani; Stephen A Lyons; John R Arrand
Epstein-Barr virus promotes human monocyte survival and maturation through a paracrine induction of IFN-alpha.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(1):321-31.
2003: Xin-Min Gou; Yan Chen; Xiao-Yi Chen; John R Arrand
[Effects of Epstein-Barr virus latent membrane protein 1(EBV-LMP1) on related factors of metastasis of nasopharyngeal carcinoma cell line CNE1].
Ai zheng = Aizheng = Chinese journal of cancer 2003;22(5):481-5.
2002: Shahram Salek-Ardakani; John R Arrand; Mike Mackett
Epstein-Barr virus encoded interleukin-10 inhibits HLA-class I, ICAM-1, and B7 expression on human monocytes: implications for immune evasion by EBV.
Virology 2002;304(2):342-51.
2002: Hal B Jenson; Yasmin Ench; Yanjin Zhang; Shou-Jiang Gao; John R Arrand; Mike Mackett
Characterization of an Epstein-Barr virus-related gammaherpesvirus from common marmoset (Callithrix jacchus).
The Journal of general virology 2002;83(Pt 7):1621-33.
2002: Shahram Salek-Ardakani; Amanda D Stuart; Jane E Arrand; Steve Lyons; John R Arrand; Mike Mackett
High level expression and purification of the Epstein-Barr virus encoded cytokine viral interleukin 10: efficient removal of endotoxin.
Cytokine 2002;17(1):1-13.
2001: J Nicholls; Elisabeth Kremmer; CA Meseda; Mike Mackett; Peter Hahn; Margaret L Gulley; A Brink; Lode J Swinnen; J Greenspan; Y De Souza; Friedrich A Grässer; Jonathan S T Sham; Mun-Hon Ng; John R Arrand
Comparative analysis of the expression of the Epstein-Barr virus (EBV) anti-apoptotic gene BHRF1 in nasopharyngeal carcinoma and EBV-related lymphoid diseases.
Journal of medical virology 2001;65(1):105-13.
2001: Y Connolly; E Littler; N Sun; X Chen; P C Huang; Simon N Stacey; John R Arrand
Antibodies to Epstein-Barr virus thymidine kinase: a characteristic marker for the serological detection of nasopharyngeal carcinoma.
International journal of cancer. Journal international du cancer 2001;91(5):692-7.
2000: Y Yao; H A Minter; X Chen; G M Reynolds; M Bromley; John R Arrand
Heterogeneity of HLA and EBER expression in Epstein-Barr virus-associated nasopharyngeal carcinoma.
International journal of cancer. Journal international du cancer 2000;88(6):949-55.
2000: Shahram Salek-Ardakani; John R Arrand; D Shaw; Mike Mackett
Heparin and heparan sulfate bind interleukin-10 and modulate its activity.
Blood 2000;96(5):1879-88.
2000: Simon N Stacey; D Jordan; A J Williamson; Michael Brown; J H Coote; John R Arrand
Leaky scanning is the predominant mechanism for translation of human papillomavirus type 16 E7 oncoprotein from E6/E7 bicistronic mRNA.
Journal of virology 2000;74(16):7284-97.
2000: CA Meseda; John R Arrand; Mike Mackett
Herpesvirus papio encodes a functional homologue of the Epstein-Barr virus apoptosis suppressor, BHRF1.
The Journal of general virology 2000;81(Pt 7):1801-5.
2000: Hal B Jenson; Yasmin Ench; Shou-Jiang Gao; K Rice; D Carey; Ronald C Kennedy; John R Arrand; Mike Mackett
Epidemiology of herpesvirus papio infection in a large captive baboon colony: similarities to Epstein-Barr virus infection in humans.
The Journal of infectious diseases 2000;181(4):1462-6.
1999: Michael Brown; D H Davies; M A Skinner; G Bowen; SJ Hollingsworth; Ghulam J Mufti; John R Arrand; Simon N Stacey
Antigen gene transfer to cultured human dendritic cells using recombinant avipoxvirus vectors.
Cancer gene therapy 1999;6(3):238-45.
1999: S J Longhurst; Joseph Rafferty; John R Arrand; Nenita G Cortez; C Giraud; K I Berns; Leslie J Fairbairn
Recombinant adeno-associated virus-mediated expression of O6-alkylguanine-DNA-alkyltransferase protects human epithelial and hematopoietic cells against chloroethylating agent toxicity.
Human gene therapy 1999;10(2):301-10.
1998: C Cox; B A Naylor; Mike Mackett; John R Arrand; Beverly E Griffin; Nina Wedderburn
Immunization of common marmosets with Epstein-Barr virus (EBV) envelope glycoprotein gp340: effect on viral shedding following EBV challenge.
Journal of medical virology 1998;55(4):255-61.
1997: M A Papworth; A A Van Dijk; G R Benyon; Terence Allen; John R Arrand; Mike Mackett
The processing, transport and heterologous expression of Epstein-Barr virus gp110.
The Journal of general virology 1997;78 ( Pt 9)():2179-89.
1997: Mike Mackett; James P Stewart; S de V Pepper; M Chee; S Efstathiou; A A Nash; John R Arrand
Genetic content and preliminary transcriptional analysis of a representative region of murine gammaherpesvirus 68.
The Journal of general virology 1997;78 ( Pt 6)():1425-33.
1997: Leslie J Fairbairn; Linda S Lashford; Elaine Spooncer; R H McDermott; G Lebens; J E Arrand; John R Arrand; Ilaria Bellantuono; R Holt; C E Hatton; Alan Cooper; G T N Besley; James Wraith; D S Anson; J J Hopwood; TM Dexter
Towards gene therapy of Hurler syndrome.
Casopís lékar̆ů c̆eských 1997;136(1):27-31.
1997: L Rocha-Zavaleta; D Jordan; S Pepper; G Corbitt; F Clarke; Norman J Maitland; Cyril M Sanders; John R Arrand; Peter L Stern; Simon N Stacey
Differences in serological IgA responses to recombinant baculovirus-derived human papillomavirus E2 protein in the natural history of cervical neoplasia.
British journal of cancer 1997;75(8):1144-50.
1996: Jim J Egan; James P Stewart; P S Hasleton; Nizar Yonan; P Bishop; John R Arrand; AN Rahman; K B Carroll; Ashley Woodcock
Epstein-Barr virus associated graft failure following heart/lung transplantation.
Thorax 1996;51(11):1160-2; discussion 1164-5.
1996: Mike Mackett; C Cox; S D Pepper; J F Lees; B A Naylor; Nina Wedderburn; John R Arrand
Immunisation of common marmosets with vaccinia virus expressing Epstein-Barr virus (EBV) gp340 and challenge with EBV.
Journal of medical virology 1996;50(3):263-71.
1996: James P Stewart; N J Janjua; S D Pepper; G Bennion; Mike Mackett; T Allen; Anthony A Nash; John R Arrand
Identification and characterization of murine gammaherpesvirus 68 gp150: a virion membrane glycoprotein.
Journal of virology 1996;70(6):3528-35.
1996: S D Pepper; James P Stewart; John R Arrand; Mike Mackett
Murine gammaherpesvirus-68 encodes homologues of thymidine kinase and glycoprotein H: sequence, expression, and characterization of pyrimidine kinase activity.
Virology 1996;219(2):475-9.
1995: Jim J Egan; James P Stewart; P S Hasleton; John R Arrand; K B Carroll; Ashley Woodcock
Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis.
Thorax 1995;50(12):1234-9.
1995: A D Stuart; James P Stewart; John R Arrand; Mike Mackett
The Epstein-Barr virus encoded cytokine viral interleukin-10 enhances transformation of human B lymphocytes.
Oncogene 1995;11(9):1711-9.
1995: Simon N Stacey; D Jordan; P J Snijders; Mike Mackett; J M Walboomers; John R Arrand
Translation of the human papillomavirus type 16 E7 oncoprotein from bicistronic mRNA is independent of splicing events within the E6 open reading frame.
Journal of virology 1995;69(11):7023-31.
1995: M N Wrightham; James P Stewart; N J Janjua; S D Pepper; C Sample; Cliona M Rooney; John R Arrand
Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1.
Virology 1995;208(2):521-30.
1994: J S Bartholomew; Simon N Stacey; B Coles; D J Burt; John R Arrand; Peter L Stern
Identification of a naturally processed HLA A0201-restricted viral peptide from cells expressing human papillomavirus type 16 E6 oncoprotein.
European journal of immunology 1994;24(12):3175-9.
1994: James P Stewart; N J Janjua; N P Sunil-Chandra; Anthony A Nash; John R Arrand
Characterization of murine gammaherpesvirus 68 glycoprotein B (gB) homolog: similarity to Epstein-Barr virus gB (gp110).
Journal of virology 1994;68(10):6496-504.
1994: James P Stewart; Frederick G. Behm; John R Arrand; Cliona M Rooney
Differential expression of viral and human interleukin-10 (IL-10) by primary B cell tumors and B cell lines.
Virology 1994;200(2):724-32.
1994: Simon N Stacey; C Eklund; D Jordan; N K Smith; Peter L Stern; J Dillner; John R Arrand
Scanning the structure and antigenicity of HPV-16 E6 and E7 oncoproteins using antipeptide antibodies.
Oncogene 1994;9(2):635-45.
1994: M A Chambers; Simon N Stacey; John R Arrand; M A Stanley
Delayed-type hypersensitivity response to human papillomavirus type 16 E6 protein in a mouse model.
The Journal of general virology 1994;75 ( Pt 1)():165-9.
1993: J F Lees; J E Arrand; S D Pepper; James P Stewart; Mike Mackett; John R Arrand
The Epstein-Barr virus candidate vaccine antigen gp340/220 is highly conserved between virus types A and B.
Virology 1993;195(2):578-86.
1993: Simon N Stacey; A Ghosh; J S Bartholomew; R W Tindle; Peter L Stern; Mike Mackett; John R Arrand
Expression of human papillomavirus type 16 E7 protein by recombinant baculovirus and use for the detection of E7 antibodies in sera from cervical carcinoma patients.
Journal of medical virology 1993;40(1):14-21.
1993: James P Stewart; John R Arrand
Expression of the Epstein-Barr virus latent membrane protein in nasopharyngeal carcinoma biopsy specimens.
Human pathology 1993;24(3):239-42.
1993: A K Ghosh; N K Smith; Simon N Stacey; S S Glew; M E Connor; John R Arrand; Peter L Stern
Serological response to HPV 16 in cervical dysplasia and neoplasia: correlation of antibodies to E6 with cervical cancer.
International journal of cancer. Journal international du cancer 1993;53(4):591-6.
1993: Leslie J Fairbairn; James P Stewart; Ian N Hampson; John R Arrand; TM Dexter
Expression of Epstein-Barr virus latent membrane protein influences self-renewal and differentiation in a multipotential murine haemopoietic 'stem cell' line.
The Journal of general virology 1993;74 ( Pt 2)():247-54.
1993: James P Stewart; Alan T McGown; J Prendiville; George R Pettit; B W Fox; John R Arrand
Bryostatin 1 induces productive Epstein-Barr virus replication in latently infected cells: implications for use in immunocompromised patients.
Cancer chemotherapy and pharmacology 1993;33(1):89-91.
1992: Simon N Stacey; J S Bartholomew; A Ghosh; Peter L Stern; Mike Mackett; John R Arrand
Expression of human papillomavirus type 16 E6 protein by recombinant baculovirus and use for detection of anti-E6 antibodies in human sera.
The Journal of general virology 1992;73 ( Pt 9)():2337-45.
1992: J F Lees; A C Goodeve; J E Arrand; A K Ghosh; P H Jones; John R Arrand
Detection of EBV DNA in post-nasal space biopsy tissue from asymptomatic EBV-seropositive individuals.
Journal of medical virology 1992;37(1):30-8.
1992: X Y Chen; S D Pepper; John R Arrand
Prevalence of the A and B types of Epstein-Barr virus DNA in nasopharyngeal carcinoma biopsies from southern China.
The Journal of general virology 1992;73 ( Pt 2)():463-6.
1992: M Madej; M J Conway; A J Morgan; J Sweet; L Wallace; L F Qualtiere; John R Arrand; Mike Mackett
Purification and characterization of Epstein-Barr virus gp340/220 produced by a bovine papillomavirus virus expression vector system.
Vaccine 1992;10(11):777-82.
1991: E Littler; S A Baylis; Y Zeng; M J Conway; Mike Mackett; John R Arrand
Diagnosis of nasopharyngeal carcinoma by means of recombinant Epstein-Barr virus proteins.
Lancet 1991;337(8743):685-9.
1991: M E Martin; B J Thomson; R W Honess; M A Craxton; Ursula A Gompels; M Y Liu; E Littler; John R Arrand; I Teo; M D Jones
The genome of human herpesvirus 6: maps of unit-length and concatemeric genomes for nine restriction endonucleases.
The Journal of general virology 1991;72 ( Pt 1)():157-68.
1990: E Littler; W Newman; John R Arrand
Immunological response of nasopharyngeal carcinoma patients to the Epstein-Barr-virus-coded thymidine kinase expressed in Escherichia coli.
International journal of cancer. Journal international du cancer 1990;45(6):1028-32.
1990: Mike Mackett; M J Conway; John R Arrand; R S Haddad; L M Hutt-Fletcher
Characterization and expression of a glycoprotein encoded by the Epstein-Barr virus BamHI I fragment.
Journal of virology 1990;64(6):2545-52.
1990: Mike Mackett; E Littler; R Michael; M Gartland; John R Arrand
Vectors with multiple insertion sites for expression of cloned genes by T7 RNA polymerase: expression of a peptide from EBV thymidine kinase (TK).
Nucleic acids research 1990;18(4):1082.
1990: E Littler; G Lawrence; M Y Liu; B G Barrell; John R Arrand
Identification, cloning, and expression of the major capsid protein gene of human herpesvirus 6.
Journal of virology 1990;64(2):714-22.
1989: James P Stewart; Ian N Hampson; H W Heinrich; Mike Mackett; John R Arrand
Enhanced expression of the Epstein-Barr virus latent membrane protein by a recombinant vaccinia virus.
The Journal of general virology 1989;70 ( Pt 5)():1231-7.
1989: John R Arrand; L S Young; J D Tugwood
Two families of sequences in the small RNA-encoding region of Epstein-Barr virus (EBV) correlate with EBV types A and B.
Journal of virology 1989;63(2):983-6.
1988: E Littler; John R Arrand
Characterization of the Epstein-Barr virus-encoded thymidine kinase expressed in heterologous eucaryotic and procaryotic systems.
Journal of virology 1988;62(10):3892-5.
1988: E Littler; I W Halliburton; K L Powell; B W Snowden; John R Arrand
Immunological conservation between Epstein-Barr virus and herpes simplex virus.
The Journal of general virology 1988;69 ( Pt 8)():2021-31.
1986: E Littler; J Zeuthen; alison mcbride; E Trøst Sørensen; K L Powell; J E Walsh-Arrand; John R Arrand
Identification of an Epstein-Barr virus-coded thymidine kinase.
The EMBO journal 1986;5(8):1959-66.